SCHEMBL7495994

SCHEMBL7495994

Cc1ccc2c(c1)[N]CC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 2/20 0.35
PARP1 P09874 1/20 0.35
HTR5A P47898 2/20 0.34
CYP19A1 P11511 4/20 0.34
CYP11B2 P19099 2/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2A6 P11509 2/20 0.33
ADRA2A P08913 1/20 0.33
ALDH1A1 P00352 2/20 0.33
METAP1 P53582 2/20 0.32
ACHE P22303 1/20 0.32
CYP2D6 P10635 1/20 0.32
RAB9A P51151 2/20 0.32
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
KDM4E B2RXH2 1/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4572833 0.83 PARP10 (0.35) PARP10PARP1HTR5ACYP19A1CYP11B2
SCHEMBL7939997 0.79 HTR5A (0.36) PARP10PARP1HTR5ACYP19A1CYP11B2
SCHEMBL9404985 0.74 PBRM1 (0.39) CYP19A1
SCHEMBL5540692 0.74 PNMT (0.38) PARP10PARP1CYP19A1CYP11B2ADRA2A
SCHEMBL1090905 0.74 HTR2A (0.41) PARP10PARP1HTR5AADRA2AACHE
SCHEMBL884168 0.74 PARP1 (0.35) PARP10PARP1HTR5ACYP19A1CYP11B2
SCHEMBL2616772 0.72 NPC1 (0.38) PARP10PARP1HTR5ACYP19A1CYP11B2
SCHEMBL1091474 0.71 ALDH1A1 (0.38) PARP10HTR5AALDH1A1ACHENOS3
SCHEMBL7934329 0.71 PARP10 (0.33) PARP10PARP1HTR5ACYP19A1CYP11B2
SCHEMBL1090437 0.69 ACHE (0.37) PARP10PARP1HTR5ACYP19A1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888349-B1 PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 2002-05-22 EP claimed
US-6140317-A AS INHIBITORS OF PROTEIN KINASES AND HAVE ANTITUMOUR ACTIVITY NOVARTIS AG (CH) 2000-10-31 US claimed
EP-0888349-A1 PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION Novartis AG (CH) 1999-01-07 EP claimed
WO-1997027199-A1 PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1997-07-31 WO claimed
EP-0888349-B1 PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 2002-05-22 EP disclosed
US-6140317-A AS INHIBITORS OF PROTEIN KINASES AND HAVE ANTITUMOUR ACTIVITY NOVARTIS AG (CH) 2000-10-31 US disclosed
EP-0888349-A1 PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION Novartis AG (CH) 1999-01-07 EP disclosed
WO-1997027199-A1 PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1997-07-31 WO disclosed